Clinical Trials
823 trialsVirotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
National Institutes of Health Clinical Center (CC)
A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
Seattle Children's Hospital
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer
University of Southern California
SPARTAN
Aragon Pharmaceuticals, Inc.
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Aragon Pharmaceuticals, Inc.
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
TITAN
Aragon Pharmaceuticals, Inc.
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Aragon Pharmaceuticals, Inc.
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
CHRYSALIS
Janssen Research & Development, LLC
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MajesTEC-1
Janssen Research & Development, LLC
B-FAST
Hoffmann-La Roche
Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia
Seattle Children's Hospital
Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA
University of Southern California
Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Case Comprehensive Cancer Center
MonumenTAL-1
Janssen Research & Development, LLC
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development, LLC
POTEN-C
University of Texas Southwestern Medical Center
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
University of Oklahoma
MAGNITUDE
Janssen Research & Development, LLC
PROTEUS
Janssen Research & Development, LLC
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
National Institutes of Health Clinical Center (CC)
BEPCOME-MB
UNICANCER
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
Janssen Research & Development, LLC
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Janssen Research & Development, LLC
CARTITUDE-2
Janssen Research & Development, LLC
MK-7075 (Miransertib) in Proteus Syndrome
National Institutes of Health Clinical Center (CC)
Cyto-KIK
Columbia University
YATAGARASU
Janssen Pharmaceutical K.K.
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
National Cancer Institute (NCI)
NeoADAURA
AstraZeneca
AMPLITUDE
Janssen Research & Development, LLC
PRIMORDIUM
Janssen Pharmaceutica N.V., Belgium
TeaMOUT
VA Office of Research and Development
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
Janssen Research & Development, LLC
PALOMA
Janssen Research & Development, LLC
KEYNOTE-B21
Merck Sharp & Dohme LLC
SunRISe-1
Janssen Research & Development, LLC
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Janssen Research & Development, LLC
SunRISe-2
Janssen Research & Development, LLC
ARX517
Janssen Research & Development, LLC
MajesTEC-2
Janssen Research & Development, LLC
Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer
University of Southern California
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
Janssen Research & Development, LLC
CARTITUDE-5
Janssen Research & Development, LLC
SOLSTICE
Janssen Research & Development, LLC